Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2018
CAMBRIDGE, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) — Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the […]